Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity.
Drinković N, Beus M, Barbir R, Debeljak Ž, Tariba Lovaković B, Kalčec N, Ćurlin M, Bekavac A, Gorup D, Mamić I, Mandić D, Micek V, Turčić P, Günday-Türeli N, Türeli E, Vinković Vrček I.
Drinković N, et al. Among authors: vinkovic vrcek i.
Nanoscale. 2024 May 16;16(19):9412-9425. doi: 10.1039/d3nr06269d.
Nanoscale. 2024.
PMID: 38650478